Bruce E. Brockstein, MD | Authors

Oral 5-FU Alternatives for the Treatment of Head and Neck Cancer

October 01, 1998

The common clinical presentations of head and neck cancer include early (stage I or II) disease, locally or regionally advanced (stage III or IV, M0) disease, and recurrent or metastatic disease (< 5% of patients).